Edition:
India

Yield10 Bioscience Inc (YTEN.OQ)

YTEN.OQ on NASDAQ Stock Exchange Capital Market

5.53USD
11 Dec 2017
Change (% chg)

$3.55 (+179.29%)
Prev Close
$1.98
Open
$2.20
Day's High
$8.67
Day's Low
$2.20
Volume
3,147,074
Avg. Vol
38,371
52-wk High
$9.20
52-wk Low
$1.93

Chart for

About

Yield10 Bioscience, Inc., formerly Metabolix, Inc., is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant... (more)
No analyst recommendations are available for .

Overall

Beta: 3.60
Market Cap(Mil.): $11.16
Shares Outstanding(Mil.): 3.45
Dividend: --
Yield (%): --

Financials

BRIEF-Yield10 Bioscience Grants Research License To Monsanto To Evaluate Two Novel Yield Traits In Soybean

* YIELD10 BIOSCIENCE INC - ‍GRANTED A NON-EXCLUSIVE RESEARCH LICENSE TO MONSANTO COMPANY TO EVALUATE ITS NOVEL C3003 AND C3004 YIELD TRAITS IN SOYBEAN​

11 Dec 2017

BRIEF-Yield10 Bioscience posts Q3 loss $0.59/shr from continuing operations

* Yield10 Bioscience announces third quarter 2017 financial results

10 Nov 2017

BRIEF-‍Yield10 Bioscience obtains confirmation of nonregulated status from USDA-APHIS for its genome-edited Camelina line​

* ‍Yield10 bioscience obtains confirmation of nonregulated status from USDA-APHIS for its genome-edited Camelina line​ Source text for Eikon: Further company coverage:

05 Sep 2017

BRIEF-Yield10 Bioscience Q2 loss per share $0.96 from continuing operations

* Yield10 Bioscience announces second quarter 2017 financial results

11 Aug 2017

BRIEF-Yield10 Bioscience announces pricing of $2.3 mln registered direct offering

* Yield10 Bioscience announces pricing of $2.3 million registered direct offering

03 Jul 2017

Earnings vs. Estimates